A Study of LY3971297 in Participants With Heart Failure | MicrobiomeTrials← Back to trialsNCT07547540
A Study of LY3971297 in Participants With Heart Failure
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2027-11
Enrollment target: 90 participants Locations- Washington University, St Louis, Missouri, United States
- University of North Carolina, Division of Cardiology, Chapel Hill, North Carolina, United States
- Kobe University Hospital, Kobe, Japan
- Kyoto University Hospital, Kyoto, Japan
- National Cerebral and Cardiovascular Center, Suita-shi, Japan
- Kasumigaura Medical Center, Tsuchiura-shi, Japan
- Institut de Cardiologie, Chisinau, Moldova
- ARENSIA Research Clinic at Republican Clinical Hospital, Chisinau, Moldova
- University Medical Center Groningen, Groningen, Netherlands
- ARENSIA Research Clinic at County Clinical Hospital, Cluj-Napoca, Romania
ContactTrial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) orLillyTrials@Lilly.com Other microbiome trials you might be interested in
Trauma InjuryDepressionAnxietyAngerPain
Animal assisted therapy (AAT) with dogs has been shown to be beneficial for a wide range of patients with both acute and…
Boston, United StatesEst. completion Dec 2026
Heart Failure
CRT improves outcomes in heart failure patients, but class II candidates (i.e. patients presenting non-LBBB or narrow LB…
Multiple LocationsEst. completion Dec 15, 2027
Recruiting
Heart Failure With Reduced Ejection Fraction (HFrEF)
The goal of this clinical trial is to measure the effectiveness of video monitoring associated with the transition of ca…
Uberlândia, BrazilEst. completion Jun 1, 2027